Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New heart MRI could slash scan time and hassle

NCT ID NCT07613398

Diagnosis Sponsor: Matthias Stuber Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new cardiac MRI method called Free-Running Framework (FRF) that lets patients breathe normally and skips the sticky ECG electrodes. It captures a 3D image of the whole heart in one go, potentially making scans faster and more comfortable. Researchers will compare FRF results with standard MRI in 300 adults with heart disease across 18 centers to see if it's just as accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Sep 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will prospectively include 300 patients (\~15-20 per site) with known or suspected cardiac disease who are referred for a clinically indicated CMR scan as part of their routine clinical work-up.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with cardiac disease of any complexity and scheduled for a clinical cardiac MRI on a clinical 1.5T MRI scanner * Able to understand and provide written informed consent or, for minors, ability to provide assent with written consent from a parent/legal representative, per local law and site policy prior to the study * Ability to undergo MRI without contraindications * Agrees to be informed in the event of incidental findings Exclusion Criteria: * Severe claustrophobia preventing MRI completion * Presence of non-MRI compatible implants (e.g., pacemakers, certain metallic implants) * Contraindications to the intravenous contrast agent * Movement disorders or inability to remain still during the scan

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congenital heart disease heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac diseases Congenital heart diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    20 sites in 10 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ann & Robert H Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611, United States

  • Boston's Children Hospital

    Boston, Massachusetts, 02115, United States

  • Charité - Universitätsmedizin Berlin

    Berlin, State of Berlin, 10117, Germany

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Cologne University Medical Center

    Cologne, North Rhine-Westphalia, 50931, Germany

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Fundacion Cardioinfantil-LaCardio

    Bogotá, Capital District, 111156, Colombia

  • King's College London

    London, London, WC2R2LS, United Kingdom

  • Maastricht University Medical Center

    Maastricht, Limburg, 6229 HX, Netherlands

  • Mayo Clinic

    Rochester, Minnesota, 55902, United States

  • Mie University

    Tsu, Mie-ken, 514-8507, Japan

  • National University of Singapore

    Singapore, Singapore, 119275, Singapore

  • Ohio State University

    Columbus, Ohio, 43210, United States

  • UT Southwestern Medical Center

    Dallas, Texas, 75390, United States

  • University of Bonn

    Bonn, North Rhine-Westphalia, 53113, Germany

  • University of California, Los Angeles

    Los Angeles, California, 90095, United States

  • University of Cape Town

    Cape Town, Western Cape, 7700, South Africa

  • University of Melbourne

    Melbourne, Victoria, 3010, Australia

  • Università Cattolica - Fondazione Policlinico Gemelli IRCCS

    Rome, Lazio, 00168, Italy

  • Washington University in St. Louis

    St Louis, Missouri, 63130, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.